Do we need another colchicine trial? Professor Sanjay Patel
Sanjay Patel MBBS (Hons 1) PhD FRACP FCSANZ is a Senior Staff Interventional Cardiologist and Director of the Cardiac Catheterisation Laboratories at Royal Prince Alfred Hospital; Clinical Professor at the Sydney Medical School and NHMRC Clinical Trials Centre; and Head of the Coronary Diseases Group at the Heart Research Institute. He was awarded his MBBS (Hons 1) from the University of Sydney in 2000; completed his advanced cardiology training at Royal Prince Alfred Hospital in 2006; and his PhD in 2009, supported by a NHF postgraduate research scholarship. He then undertook postdoctoral studies at Stanford University, whilst simultaneously training in Interventional Cardiology at Stanford University Medical Centre (2009-2010), supported by an NHMRC CJ Martin Overseas Fellowship Grant.
As a cardiovascular researcher, he has published over 100 research papers and leads a program which aims to develop novel therapies to target atherosclerosis and its consequences, specifically targeting the inflammation that drives coronary plaque instability. This program has attracted over >$13 million in peer-reviewed research funding. He currently co-leads multiple NHMRC-funded international trials of colchicine in ACS, stroke and Long Covid-19 patients.
Zoom link: https://zoom.us/j/93278404518
May 05 2023